Wave Life Sciences (WVE) Shares Outstanding (2014 - 2026)

Wave Life Sciences (WVE) has 13 years of Shares Outstanding (Entity) data on file, last reported at $197.0 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 26.58% year-over-year to $197.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $197.0 million (up 26.58% YoY) and the FY2025 annual result came in at $187.7 million, up 22.62% from the prior year.
• Shares Outstanding (Entity) grew to $197.0 million in Q2 2026, from $192.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $197.0 million in Q2 2026 to a low of $60.9 million in Q1 2022.
• A 5-year average of $128.3 million and a median of $122.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 67.01% — and 2025, when it grew 8.02%.
• Tracing WVE's Shares Outstanding (Entity) over 5 years: stood at $86.9 million in 2022, then surged by 37.09% to $119.2 million in 2023, then climbed by 28.43% to $153.0 million in 2024, then climbed by 22.62% to $187.7 million in 2025, then climbed by 5.0% to $197.0 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $197.0 million (Q2 2026), $192.3 million (Q1 2026), and $187.7 million (Q4 2025), per Business Quant data.